Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Fluorescence Biomodulation (FB) is a novel technology that employs fluorescence light energy (FLE) to positively impact the three phases of healing. In the clinical setting, FB has been demonstrated to be safe and effective in the management of both acute and chronic wounds, resulting in accelerated wound closure while reducing inflammation, bacterial growth, and pain. The objective of this research project is to determine how FLE impacts biological pathways in the healing process to realize these observed clinical effects. Klox Technologies (the partner organization) is a Canadian start-up company in biomedical technologies. The proposed research help Klox better understand and explain the biological impact of Fluorescence Biomodulation, which will aid in the development of new advanced wound care products and improve patient care with better treatment options for hard-to-heal wounds.
David R Hipfner
Mehrnoush Dehghani
Klox Technologies
Medicine
Université de Montréal
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.